TB Archives – Page 38 of 51 – Treatment Action Group

A Double Blow: Private-Sector Funding for TB Research Drops Sharply Amid Severe Public-Sector Budget Cuts

October 29, 2013
Chad Cipiti

The 2013 Report on Tuberculosis Research Funding Trends, 2005–2012 finds that funding for tuberculosis research and development (TB R&D) dropped by US$30.4 million compared with 2011—the first time funding has fallen since TAG began tracking investments in 2005. Funding declined for diagnostic, drug, vaccine, and operational research, increasing the likelihood that new tools to fight TB will remain out of reach for the 8.7 million people who develop TB each year.

2013 Report on TB Research Funding Trends

October 25, 2013
Chad Cipiti

2013 Report on Tuberculosis Research Funding Trends, 2005–2012 NOVEMBER 2013 BY Mike Frick and Eleonora Jiménez-Levi Edited by Mark Harrington From the Executive Summary Over the last eight years, Treatment Action Group (TAG) has tracked annual spending on tuberculosis research…

An Obligatory Overhaul to Address Domestic TB Drug Shortages

October 4, 2013
Chad Cipiti

Bold strategies are required to remedy frequent stock-outs and supply interruptions By Lindsay McKenna Drug shortages, especially of tuberculosis (TB) drugs, have become increasingly common in the United States. Over the past year alone, the U.S. Centers for Disease Control…

U.S. TB Control: From Confidence to Crisis

October 4, 2013
Chad Cipiti

Funding cuts and shifting budgetary priorities threaten tuberculosis gains By Coco Jervis The United States is losing ground in its fight against the tuberculosis (TB) epidemic within its own borders. Sequestration and shifting priorities of Congress and the Obama administration…

TAGline Fall 2013

October 4, 2013
Chad Cipiti

The Domestic Issue: We're at a stalemate. This issue of TAGline underscores TAG’s commitment to ending AIDS in the United States and realizing the goals of the National HIV/AIDS Strategy.

Roadmap for Childhood TB: Towards Zero Deaths

October 1, 2013
Chad Cipiti

The World Health Organization, the International Union Against Tuberculosis and Lung Disease, the Stop TB Partnership and other partners will launch a roadmap outlining the path towards zero deaths from childhood tuberculosis.

First-Ever Targeted Roadmap Outlines Steps to End Childhood TB Deaths

October 1, 2013
Chad Cipiti

Cost to end deaths from childhood TB estimated to be at least US$120 million annually WASHINGTON D.C. | October 1, 2013 -- The deaths of more than 74 000 children from tuberculosis (TB) could be prevented each year through measures outlined…

Treatment Action Group Criticizes European Refusal of New Drug to Fight Tuberculosis

July 26, 2013
Chad Cipiti

Treatment Action Group (TAG) is disappointed by the failure of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) to recommend marketing approval for delamanid, a new drug in development for multidrug-resistant tuberculosis (MDR-TB).

2013 Pipeline Report

June 29, 2013
Chad Cipiti

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development: Written by Polly Clayden, Simon Collins, Colleen Daniels, Mike Frick, Mark Harrington, Tim Horn, Richard Jefferys, Karyn Kaplan, Erica Lessem, and Tracy Swan

TB Quick Facts

May 10, 2013
Chad Cipiti

What Is Tuberculosis (TB)? Mycobacterium tuberculosis (MTB) is a type of bacterium (sometimes called a bug) that, for thousands of years, has caused TB disease (called consumption in the past). TB remains a major, if often unnoticed, problem today. TB…